Form 8-K - Current report:
SEC Accession No. 0001140361-21-011725
Filing Date
2021-04-06
Accepted
2021-04-06 07:00:55
Documents
12
Period of Report
2021-04-06
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K brhc10022825_8k.htm   iXBRL 8-K 26108
  Complete submission text file 0001140361-21-011725.txt   163691

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20210406.xsd EX-101.SCH 4204
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20210406_lab.xml EX-101.LAB 22718
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20210406_pre.xml EX-101.PRE 16222
5 EXTRACTED XBRL INSTANCE DOCUMENT brhc10022825_8k_htm.xml XML 4062
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 21808089
SIC: 2834 Pharmaceutical Preparations